欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4539/001
药品名称Sativex Oromucosal Spray
活性成分
    • Delta-9-Tetrahydrocannabinol 27.0 mg/ml
剂型Oromucosal spray
上市许可持有人GW Pharma (International) B.V. Databankweg 26 3821 AL Amersfoort The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Sativex, spray voor oromucosaal gebruik
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Spain (ES)
    • France (FR)
    • Germany (DE)
      Sativex, 2183727
    • Denmark (DK)
      Sativex
    • Austria (AT)
      Sativex Spray zur Anwendung in der Mundhöhle
    • Italy (IT)
    • Sweden (SE)
    • Czechia (CZ)
      Sativex® Oromucosal Spray
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • Ireland (IE)
    • Portugal (PT)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Sativex
    • Slovakia (SK)
      Sativex orálna aerodisperzia
许可日期2010/05/18
最近更新日期2025/06/02
药物ATC编码
    • N02BG10 cannabinoids
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase